You are Trying to View a Premium Article

Daily News You Can't Find Anywhere Else

Novartis Axing 320 Jobs at Irish Manufacturing Plant

pharmaceutical

Industry Segment: Pharmaceutical & Biotech | Word Count: 693 Words

GALWAY, IRELAND--November 4, 2019--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Swiss pharmaceutical company Novartis International AG (NYSE:NVS) (Basel, Switzerland) is axing more than half of the employees at its Irish active pharmaceutical ingredient (API) manufacturing operation at the Ringaskiddy campus in Cork by mid-2022.

Within this article: Details job cuts, impact, related activities in Europe

This Premium Article can be purchased individually or as part of a subscription

Subscribe Now! All Fields Required...

Subscription Type: Pricing Help?

  • Pay-Per-Article - $3.95
  • Annual Subscription - $235.00
  • Annual Subscription with Archive - $395.00